Production (Stage)
Generation Bio Co.
GBIO
$0.3706
-$0.0124-3.24%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.80M | -21.38M | -15.31M | -20.43M | -74.54M |
| Total Depreciation and Amortization | 1.14M | 1.18M | 1.18M | 1.26M | 1.31M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.16M | 5.30M | 2.50M | 3.21M | 58.60M |
| Change in Net Operating Assets | -16.85M | -875.00K | -7.92M | -5.58M | -17.06M |
| Cash from Operations | -28.36M | -15.78M | -19.55M | -21.54M | -31.70M |
| Capital Expenditure | -246.00K | -378.00K | -91.00K | -14.00K | -1.92M |
| Sale of Property, Plant, and Equipment | 30.00K | 47.00K | 45.00K | 104.00K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 3.17M | 70.62M | 12.75M | 12.00M | 1.37M |
| Cash from Investing | 2.96M | 70.28M | 12.71M | 12.09M | -553.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 158.00K | 13.00K | 265.00K | -- |
| Repurchase of Common Stock | -7.00K | -14.00K | -16.00K | -31.00K | -125.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -7.00K | 144.00K | -3.00K | 234.00K | -125.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -25.41M | 54.64M | -6.84M | -9.21M | -32.38M |